There is a drive towards delivering and operating public infrastructure through publicprivate partnership rather than traditional public procurement. The assessment of the value for money achieved by the two alternative approaches rests in the cost of financing and their efficiency in delivery and operation. This paper focuses on the cost of financing, in particular the cost associated with transferring risk from the public to private sphere. If capital markets were efficient and complete, the cost of public (government) and private financing should be the same, with the relative delivery and operational efficiency remaining as the primary determinant of value for money. Evidence suggests, however, that the risk transfer to a public-private partnership entails an inefficient risk pricing premium which goes beyond the direct cost of financing. We argue that a high price for public-private partnerships results from large risk transfers, risk treatment within the private sector, and uncertainty around the past and future performance of public-private consortia. The corollary is that the efficiency gains from a public-private partnership must be much higher than commonly expected to deliver a greater value for the money than under a traditional approach.
There is a drive towards delivering and operating public infrastructure through publicprivate partnership rather than traditional public procurement. The assessment of the value for money achieved by the two alternative approaches rests in the cost of financing and their efficiency in delivery and operation. This paper focuses on the cost of financing, in particular the cost associated with transferring risk from the public to private sphere. If capital markets were efficient and complete, the cost of public (government) and private financing should be the same, with the relative delivery and operational efficiency remaining as the primary determinant of value for money. Evidence suggests, however, that the risk transfer to a public-private partnership entails an inefficient risk pricing premium which goes beyond the direct cost of financing. We argue that a high price for public-private partnerships results from large risk transfers, risk treatment within the private sector, and uncertainty around the past and future performance of public-private consortia. The corollary is that the efficiency gains from a public-private partnership must be much higher than commonly expected to deliver a greater value for the money than under a traditional approach.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.